Chemoinformaics analysis of (2s,3s)-glucodistylin
| Molecular Weight | 466.395 | nRot | 4 |
| Heavy Atom Molecular Weight | 444.219 | nRig | 24 |
| Exact Molecular Weight | 466.111 | nRing | 4 |
| Solubility: LogS | -3.253 | nHRing | 2 |
| Solubility: LogP | -0.292 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 12 | APOL | 59.3634 |
| nHD | 8 | BPOL | 28.1466 |
| QED | 0.256 |
| Synth | 4.344 |
| Natural Product Likeliness | 2.494 |
| NR-PPAR-gamma | 0.319 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.032 |
| HIA | 0.783 |
| CACO-2 | -6.668 |
| MDCK | 0.00000614 |
| BBB | 0.073 |
| PPB | 0.904701 |
| VDSS | 0.542 |
| FU | 0.138628 |
| CYP1A2-inh | 0.052 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.048 |
| CYP2c9-sub | 0.278 |
| CYP2d6-inh | 0.095 |
| CYP2d6-sub | 0.189 |
| CYP3a4-inh | 0.335 |
| CYP3a4-sub | 0.07 |
| CL | 4.552 |
| T12 | 0.687 |
| hERG | 0.184 |
| Ames | 0.677 |
| ROA | 0.062 |
| SkinSen | 0.929 |
| Carcinogencity | 0.167 |
| EI | 0.794 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.312 |
| Antiviral | Yes |
| Prediction | 0.821502 |